Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria V. Barabanshchikova"'
Publikováno v:
Clinical oncohematology. 14:45-52
Ph-negative myeloproliferative neoplasms (MPN) are rare oncohematological diseases characterized by long duration and indolence. World epidemiological data on these diseases considerably vary depending on geographical area and time frame of the study
Publikováno v:
Cellular Therapy and Transplantation. 9:28-39
The aim of this paper was to present evaluation and synthesis of data derived from a survey of Russian patients and physicians, performed as a part of the international Landmark study for the emerging market countries designed to specify problems and
Autor:
E. Kondakova, Julia Yu. Vlasova, Ludmila S. Zubarovskaya, Maria V. Barabanshchikova, Maria Ivanova, Darya A. Zvyagintseva, Kirill V. Lepik, Elena E. Lepik, TA Bykova, M. Popova, Natalya B. Mikhailova, Asmik Gevorgian, Ivan S. Moiseev, Andrey V. Kozlov, Ivan V. Tsygankov, Olesya Smykova, Alexey Polushin, Lyudmila V. Fedorova, Ksenia S. Afanasyeva, Elena V. Morozova, Polina S. Tolkunova, I. V. Kazantsev, Yury R. Zalyalov, Olga V. Kudyasheva, Yury Punanov, Inna V. Markova, Sergey N. Bondarenko, Anna G. Smirnova, E.V. Semenova, O.V. Paina, Olga B. Kalashnikova, Anna A. Osipova, Tatyana V. Yukhta, Boris V. Afanasyev, Elena I. Darskaya, Irina A. Mikhailova, OV Pirogova, Alexander D. Kulagin, Valentina V. Porunova, Vladislav O. Korolenko, Nikolay Yu. Tcvetkov, Irina K. Golubovskaya
Publikováno v:
Cellular Therapy and Transplantation. 8:101-145
Autor:
Ildar M. Barkhatov, M.V. Vladovskaya, AL Alyanskii, Maria V. Barabanshchikova, Yu.Yu. Vlasova, NN Mamaev, Boris V. Afanasyev, E.L. Darskaya, Elena V. Morozova, Sergey N. Bondarenko, Ivan S. Moiseev
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 2, Pp 193-198 (2019)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a radical method of chronic myeloid leukemia (CML) treatment. In the 1990s CML became the most frequent indication for allo-HSCT worldwide. CML treatment drastically changed after tyro
Autor:
Julia Yu. Vlasova, Maria V. Barabanshchikova, Irina Martynkevich, Boris V. Afanasyev, Vasily Shuvaev, I. Barhatov, Anna G. Turkina, Tatiana Gindina, Elena V. Morozova, Oleg Shukhov
Publikováno v:
Cellular Therapy and Transplantation. 6:26-35
Autor:
BV Afanas’ev, Sergey N. Bondarenko, Maria V. Barabanshchikova, Ildar M. Barkhatov, Elena V. Morozova, L.S. Zubarovskaya, AL Alyanskii, V. Baykov, NN Mamaev
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 3, Pp 279-286 (2016)
Background & Aims. At present, the allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only treatment option with curative potential in patients with myelofibrosis (MF), especially in intermediate and high risk categories. The aim o
Autor:
BV Afanas’ev, Elena V. Morozova, Ivan S. Moiseev, OV Pirogova, NN Mamaev, MO Ivanova, Sergey N. Bondarenko, EN Nikolaeva, YuYu Vlasova, TL Gindina, IA Petrova, V.V. Baikov, Maria V. Barabanshchikova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 1, Pp 61-69 (2016)
Aim. To evaluate the potential of a new cytogenetic technique in patients with primary myelofibrosis (PMF). Materials and methods. 48-hour blood cell cultures (according to Singh et al., 2013) were used for cytogenetic study in 11 PMF patients (5 fem